AVXL - CIK 0001314052
ANAVEX LIFE SCIENCES CORP. has filed 584 documents with the SEC between 2005 and 2026. The most frequent type is insider trade (167 filings), alongside the regular cadence of annual reports, quarterly reports, and event disclosures every public company must make. Use the filters to focus on one filing type, or flip the sort to trace the company's history from its earliest paperwork.
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.
| Filing | Type | Filed | Period covered |
|---|---|---|---|
| Major company event | 8-K | 2026-05-22 | 2026-05-20 |
| Major company event | 8-K | 2026-05-15 | 2026-05-11 |
| New insider ownership | 3 | 2026-05-14 | 2026-05-04 |
| NT 10-Q | - | 2026-05-11 | 2026-03-31 |
| Major company event | 8-K | 2026-05-06 | 2026-04-30 |
| New insider ownership | 3 | 2026-05-01 | 2026-02-23 |
| SCHEDULE 13G/A | - | 2026-03-26 | - |
| Major company event | 8-K | 2026-03-25 | 2026-03-25 |
| Major company event | 8-K | 2026-02-25 | 2026-02-20 |
| Quarterly report | 10-Q | 2026-02-09 | 2025-12-31 |
| Major company event | 8-K | 2026-02-09 | 2026-02-09 |
| Insider trade | 4 | 2026-01-09 | 2026-01-06 |
| Insider trade | 4 | 2026-01-09 | 2026-01-06 |
| Annual report | 10-K | 2025-11-25 | 2025-09-30 |
| Major company event | 8-K | 2025-11-25 | 2025-11-25 |
| Major company event | 8-K | 2025-11-14 | 2025-11-14 |
| Insider trade | 4 | 2025-10-03 | 2025-10-02 |
| Insider trade | 4 | 2025-10-03 | 2025-10-02 |
| Insider trade | 4 | 2025-09-12 | 2025-09-11 |
| Insider trade | 4 | 2025-08-22 | 2025-08-20 |
| Insider trade | 4 | 2025-08-22 | 2025-08-20 |
| Quarterly report | 10-Q | 2025-08-12 | 2025-06-30 |
| Major company event | 8-K | 2025-07-28 | 2025-07-25 |
| Prospectus supplement | 424B5 | 2025-07-25 | - |
| EFFECT | - | 2025-07-23 | - |
| Company correspondence | CORRESP | 2025-07-21 | - |
| SEC correspondence | UPLOAD | 2025-07-21 | - |
| Securities registration | S-3 | 2025-07-14 | - |
| Major company event | 8-K | 2025-07-03 | 2025-07-03 |
| Major company event | 8-K | 2025-06-13 | 2025-06-10 |
| Insider trade | 4 | 2025-06-09 | 2025-06-05 |
| Quarterly report | 10-Q | 2025-05-13 | 2025-03-31 |
| Insider trade | 4 | 2025-04-30 | 2025-04-28 |
| Insider trade | 4 | 2025-04-30 | 2025-04-28 |
| Annual report to shareholders | ARS | 2025-04-25 | 2024-09-30 |
| Proxy materials | DEFA14A | 2025-04-25 | - |
| Proxy statement | DEF 14A | 2025-04-25 | 2025-04-25 |
| Insider trade | 4 | 2025-04-02 | 2025-03-31 |
| Insider trade | 4 | 2025-04-02 | 2025-03-31 |
| Insider trade | 4 | 2025-04-02 | 2025-03-31 |
| Insider trade | 4 | 2025-04-02 | 2025-03-31 |
| Insider trade | 4 | 2025-04-02 | 2025-03-31 |
| Insider trade | 4 | 2025-03-26 | 2025-03-24 |
| Quarterly report | 10-Q | 2025-02-12 | 2024-12-31 |
| Insider trade | 4 | 2025-01-17 | 2025-01-15 |
| Insider trade | 4 | 2025-01-17 | 2025-01-15 |
| Insider trade | 4 | 2024-12-23 | 2024-12-19 |
| Insider trade | 4 | 2024-12-23 | 2024-12-19 |
| Annual report | 10-K | 2024-12-23 | 2024-09-30 |
| Insider trade | 4 | 2024-12-06 | 2024-11-19 |